Life Sciences Innovative Manufacturing Fund

R&D

Since the turn of the decade, the pharmaceuticals industry has dealt with supply chain challenges caused by both the pandemic and global conflict.

News

Following the failure of its sickle cell programme, Fulcrum Therapeutics will merge with Slate Medicines to advance Slate's migraine therapy.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.